To ask the Secretary of State for Health and Social Care, if he will publish communications on the potential continued risk to immunocompromised and immunosuppressed groups who may not receive the same level of protection from the covid-19 vaccines as the general population.
On 12 July, we published updated guidance for the clinically extremely vulnerable, including those who are immunocompromised and immunosuppressed, in light of the lifting of restrictions on 19 July. The guidance is available at the following link:
The Deputy Chief Medical Officer and NHS England’s National Medical Director wrote to clinicians on 16 July regarding immunosuppressed patients to provide an overview of the information available to date regarding vaccine efficacy in the immunosuppressed. This included additional information to inform conversations clinicians may have with patients who are immunosuppressed.